Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis continues to grow with further core margin expansion and achieves important innovation milestones
Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +4% (cc1, -2% USD) with core operating income growing +8% (cc, 0% USD) IM sales grew +4% (cc, -2% USD) and core operating
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
BASEL (dpa-AFX) - Novartis (NVS) said that its shareholders approved all resolutions proposed by the Board of Directors at the Annual General Meeting.The company's shareholders approved the 25th